Related Experiment Videos
[Inhalative application devices for patients suffering from asthma bronchiale]
M Schwald1, A Schneider, F J Meyer
1Arzneimittelinformationszentrum der Apotheke, Universitätsklinikum Heidelberg. martina.schwald@med.uni-heidelberg.de
Therapeutische Umschau. Revue Therapeutique
|July 18, 2006
Summary
Optimal use of inhaled medications for asthma and COPD requires proper inhaler technique. This guide reviews various inhalation systems to ensure effective treatment and improve patient outcomes.
Area of Science:
- Respiratory Medicine
- Pharmacology
- Medical Devices
Context:
- Asthma involves airway inflammation driven by eosinophils, mast cells, and CD4+ T-lymphocytes, leading to variable obstruction.
- COPD features inflammation from neutrophils, macrophages, and CD8+ T-lymphocytes, causing irreversible obstruction and lung parenchyma destruction.
Purpose:
- To differentiate inflammatory mechanisms and therapeutic approaches in asthma and COPD.
- To highlight the importance of optimal medication application and the challenges posed by diverse inhalation systems.
Summary:
- Inhaled corticosteroids are primary controllers for asthma, while cromones are second-line. Beta2-agonists and anticholinergics provide symptomatic relief by inducing bronchial dilatation.
- COPD treatment primarily uses symptomatic medications like anticholinergics and beta2-agonists; inhaled steroids benefit a subset of patients.
- Effective inhalation therapy hinges on patient-device coordination, yet numerous systems cause confusion, hindering optimal use.
Impact:
- Provides a comprehensive overview of inhalation device systems to aid clinicians and patients in selecting and using them effectively.
- Aims to improve patient adherence and therapeutic outcomes by clarifying the complexities of inhalation therapy systems.
- Facilitates informed decision-making regarding the most efficient application of inhalation therapy for respiratory conditions.